431 total citations 11 papers, 346 citations indexed
About
Lister Ta is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology.
According to data from OpenAlex, Lister Ta has authored 11 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Pathology and Forensic Medicine and 5 papers in Hematology. Recurrent topics in Lister Ta's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (4 papers). Lister Ta is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (4 papers). Lister Ta collaborates with scholars based in United Kingdom and United States. Lister Ta's co-authors include BD Young, Van de Ven Wj, Mark Bower, J. Amess, Gerald A. Evans, Pauline Parry, D. Crowther, Dean Nižetić, Susheela Dhut and Robert E. Kearney and has published in prestigious journals such as Blood, PubMed and UCL Discovery (University College London).
In The Last Decade
Lister Ta
11 papers
receiving
324 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Lister Ta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lister Ta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lister Ta more than expected).
This network shows the impact of papers produced by Lister Ta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lister Ta. The network helps show where Lister Ta may publish in the future.
Co-authorship network of co-authors of Lister Ta
This figure shows the co-authorship network connecting the top 25 collaborators of Lister Ta.
A scholar is included among the top collaborators of Lister Ta based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Lister Ta. Lister Ta is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
11 of 11 papers shown
1.
Wj, Van de Ven, et al.. (1996). A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas.. PubMed. 56(3). 448–51.88 indexed citations
2.
Kearney, Robert E., Dean Nižetić, Susheela Dhut, et al.. (1994). Molecular cloning of a novel 11q23 breakpoint associated with non-Hodgkin's lymphoma.. PubMed. 9(3). 893–8.12 indexed citations
Radford, John, et al.. (1990). VAPEC B: a weekly chemotherapy for high grade non-Hodgkin's lymphoma. Early results of a collaborative trial at two centres.. UCL Discovery (University College London).1 indexed citations
5.
Ta, Lister & D. Crowther. (1990). Staging for Hodgkin's disease.. PubMed. 17(6). 696–703.16 indexed citations
6.
Ta, Lister, Renato Bassan, Walter M. Gregory, et al.. (1987). Conventional dose cytosine arabinoside in combination chemotherapy for acute myelogenous leukemia.. PubMed. 14(2 Suppl 1). 53–4.4 indexed citations
7.
Ta, Lister, et al.. (1985). The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma.. PubMed. 12(2 Suppl 3). 223–6.11 indexed citations
8.
Ta, Lister, et al.. (1982). Posttreatment laparotomy as a guide to management in patients with Hodgkin's disease.. PubMed. 66(4). 759–65.13 indexed citations
9.
Hg, Prentice, et al.. (1979). Limited activity of ICRF-159 in advanced acute leukemia.. PubMed. 63(1). 127–9.9 indexed citations
Ta, Lister, et al.. (1972). The treatment of acute myelogenous leukemia in adults.. PubMed. 13(1). 172–83.53 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.